nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—BLK—rheumatoid arthritis	0.263	0.597	CbGaD
Vandetanib—VEGFA—rheumatoid arthritis	0.14	0.317	CbGaD
Vandetanib—ALB—rheumatoid arthritis	0.0376	0.0853	CbGaD
Vandetanib—ALB—Auranofin—rheumatoid arthritis	0.0329	0.154	CbGbCtD
Vandetanib—ABCG2—Leflunomide—rheumatoid arthritis	0.0308	0.144	CbGbCtD
Vandetanib—ABCC1—Cyclosporine—rheumatoid arthritis	0.0215	0.101	CbGbCtD
Vandetanib—ABCG2—Sulfasalazine—rheumatoid arthritis	0.019	0.0889	CbGbCtD
Vandetanib—ABCG2—Hydrocortisone—rheumatoid arthritis	0.0153	0.0714	CbGbCtD
Vandetanib—ABCG2—Cyclosporine—rheumatoid arthritis	0.0144	0.0674	CbGbCtD
Vandetanib—ABCC1—Methotrexate—rheumatoid arthritis	0.0114	0.0533	CbGbCtD
Vandetanib—ALB—Prednisone—rheumatoid arthritis	0.0105	0.049	CbGbCtD
Vandetanib—ABCG2—Dexamethasone—rheumatoid arthritis	0.00948	0.0444	CbGbCtD
Vandetanib—ABCG2—Methotrexate—rheumatoid arthritis	0.00762	0.0357	CbGbCtD
Vandetanib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00735	0.0344	CbGbCtD
Vandetanib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00542	0.0254	CbGbCtD
Vandetanib—ALB—Methotrexate—rheumatoid arthritis	0.00525	0.0246	CbGbCtD
Vandetanib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00411	0.0192	CbGbCtD
Vandetanib—CYP3A4—Betamethasone—rheumatoid arthritis	0.00352	0.0165	CbGbCtD
Vandetanib—CYP3A4—Prednisolone—rheumatoid arthritis	0.00348	0.0163	CbGbCtD
Vandetanib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0033	0.0154	CbGbCtD
Vandetanib—CYP3A4—Prednisone—rheumatoid arthritis	0.00328	0.0154	CbGbCtD
Vandetanib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00311	0.0146	CbGbCtD
Vandetanib—RIPK2—synovial membrane of synovial joint—rheumatoid arthritis	0.00307	0.0566	CbGeAlD
Vandetanib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00205	0.00959	CbGbCtD
Vandetanib—ORM1—saliva—rheumatoid arthritis	0.00156	0.0289	CbGeAlD
Vandetanib—ERBB3—exocrine gland—rheumatoid arthritis	0.00141	0.026	CbGeAlD
Vandetanib—Afatinib—IRAK1—rheumatoid arthritis	0.00128	0.193	CrCbGaD
Vandetanib—PTK6—saliva-secreting gland—rheumatoid arthritis	0.00124	0.0228	CbGeAlD
Vandetanib—Erlotinib—PIP4K2C—rheumatoid arthritis	0.00119	0.18	CrCbGaD
Vandetanib—TYRO3—connective tissue—rheumatoid arthritis	0.00088	0.0162	CbGeAlD
Vandetanib—BLK—lymphoid tissue—rheumatoid arthritis	0.000877	0.0162	CbGeAlD
Vandetanib—LYN—connective tissue—rheumatoid arthritis	0.000875	0.0161	CbGeAlD
Vandetanib—PTK6—digestive system—rheumatoid arthritis	0.000822	0.0152	CbGeAlD
Vandetanib—RIPK2—parotid gland—rheumatoid arthritis	0.000768	0.0142	CbGeAlD
Vandetanib—FMO1—parotid gland—rheumatoid arthritis	0.000762	0.0141	CbGeAlD
Vandetanib—IRAK4—parotid gland—rheumatoid arthritis	0.00075	0.0138	CbGeAlD
Vandetanib—FLT3—connective tissue—rheumatoid arthritis	0.000748	0.0138	CbGeAlD
Vandetanib—RIPK2—saliva-secreting gland—rheumatoid arthritis	0.000736	0.0136	CbGeAlD
Vandetanib—Bosutinib—SYK—rheumatoid arthritis	0.000735	0.111	CrCbGaD
Vandetanib—Bosutinib—PRKCQ—rheumatoid arthritis	0.000735	0.111	CrCbGaD
Vandetanib—IRAK4—saliva-secreting gland—rheumatoid arthritis	0.000718	0.0132	CbGeAlD
Vandetanib—ERBB3—saliva-secreting gland—rheumatoid arthritis	0.000704	0.013	CbGeAlD
Vandetanib—Afatinib—BLK—rheumatoid arthritis	0.000691	0.104	CrCbGaD
Vandetanib—PLK4—lymphoid tissue—rheumatoid arthritis	0.000685	0.0126	CbGeAlD
Vandetanib—RIPK2—connective tissue—rheumatoid arthritis	0.000676	0.0125	CbGeAlD
Vandetanib—FMO3—parotid gland—rheumatoid arthritis	0.000658	0.0121	CbGeAlD
Vandetanib—SLK—parotid gland—rheumatoid arthritis	0.000654	0.0121	CbGeAlD
Vandetanib—ERBB3—connective tissue—rheumatoid arthritis	0.000647	0.0119	CbGeAlD
Vandetanib—TYRO3—lymphoid tissue—rheumatoid arthritis	0.000643	0.0119	CbGeAlD
Vandetanib—LYN—lymphoid tissue—rheumatoid arthritis	0.00064	0.0118	CbGeAlD
Vandetanib—EPHA5—digestive system—rheumatoid arthritis	0.000636	0.0117	CbGeAlD
Vandetanib—SLK—saliva-secreting gland—rheumatoid arthritis	0.000626	0.0115	CbGeAlD
Vandetanib—MAP4K5—parotid gland—rheumatoid arthritis	0.000621	0.0115	CbGeAlD
Vandetanib—RET—connective tissue—rheumatoid arthritis	0.0006	0.0111	CbGeAlD
Vandetanib—AXL—connective tissue—rheumatoid arthritis	0.000598	0.011	CbGeAlD
Vandetanib—MAP4K5—saliva-secreting gland—rheumatoid arthritis	0.000595	0.011	CbGeAlD
Vandetanib—EPHB6—parotid gland—rheumatoid arthritis	0.000594	0.0109	CbGeAlD
Vandetanib—YES1—parotid gland—rheumatoid arthritis	0.000574	0.0106	CbGeAlD
Vandetanib—EPHB6—saliva-secreting gland—rheumatoid arthritis	0.000568	0.0105	CbGeAlD
Vandetanib—Gefitinib—IRAK1—rheumatoid arthritis	0.000566	0.0852	CrCbGaD
Vandetanib—FYN—connective tissue—rheumatoid arthritis	0.000559	0.0103	CbGeAlD
Vandetanib—Bosutinib—IRAK1—rheumatoid arthritis	0.000557	0.0838	CrCbGaD
Vandetanib—YES1—saliva-secreting gland—rheumatoid arthritis	0.000549	0.0101	CbGeAlD
Vandetanib—FLT3—lymphoid tissue—rheumatoid arthritis	0.000547	0.0101	CbGeAlD
Vandetanib—TEK—connective tissue—rheumatoid arthritis	0.000547	0.0101	CbGeAlD
Vandetanib—KDR—parotid gland—rheumatoid arthritis	0.000508	0.00936	CbGeAlD
Vandetanib—MAP2K5—parotid gland—rheumatoid arthritis	0.000508	0.00936	CbGeAlD
Vandetanib—YES1—connective tissue—rheumatoid arthritis	0.000505	0.00931	CbGeAlD
Vandetanib—STK35—tendon—rheumatoid arthritis	0.000504	0.00929	CbGeAlD
Vandetanib—FLT4—lymphoid tissue—rheumatoid arthritis	0.000497	0.00917	CbGeAlD
Vandetanib—ABL2—tendon—rheumatoid arthritis	0.000491	0.00906	CbGeAlD
Vandetanib—RIPK2—digestive system—rheumatoid arthritis	0.000488	0.009	CbGeAlD
Vandetanib—MAP2K5—saliva-secreting gland—rheumatoid arthritis	0.000486	0.00897	CbGeAlD
Vandetanib—KDR—saliva-secreting gland—rheumatoid arthritis	0.000486	0.00897	CbGeAlD
Vandetanib—SRC—connective tissue—rheumatoid arthritis	0.000486	0.00896	CbGeAlD
Vandetanib—FMO1—digestive system—rheumatoid arthritis	0.000484	0.00893	CbGeAlD
Vandetanib—IRAK4—lymphoid tissue—rheumatoid arthritis	0.000483	0.0089	CbGeAlD
Vandetanib—Bosutinib—PTK2—rheumatoid arthritis	0.000474	0.0713	CrCbGaD
Vandetanib—ERBB3—lymphoid tissue—rheumatoid arthritis	0.000473	0.00873	CbGeAlD
Vandetanib—ERBB3—digestive system—rheumatoid arthritis	0.000467	0.00862	CbGeAlD
Vandetanib—RIPK2—tendon—rheumatoid arthritis	0.000465	0.00857	CbGeAlD
Vandetanib—VEGFA—tendon—rheumatoid arthritis	0.000463	0.00855	CbGeAlD
Vandetanib—FMO1—tendon—rheumatoid arthritis	0.000461	0.0085	CbGeAlD
Vandetanib—IRAK4—tendon—rheumatoid arthritis	0.000454	0.00837	CbGeAlD
Vandetanib—KDR—connective tissue—rheumatoid arthritis	0.000447	0.00824	CbGeAlD
Vandetanib—MKNK1—lymphoid tissue—rheumatoid arthritis	0.000444	0.00819	CbGeAlD
Vandetanib—PDGFRB—parotid gland—rheumatoid arthritis	0.000439	0.0081	CbGeAlD
Vandetanib—MKNK1—digestive system—rheumatoid arthritis	0.000439	0.00809	CbGeAlD
Vandetanib—FGR—lymphoid tissue—rheumatoid arthritis	0.000439	0.00809	CbGeAlD
Vandetanib—RET—lymphoid tissue—rheumatoid arthritis	0.000439	0.00809	CbGeAlD
Vandetanib—AXL—lymphoid tissue—rheumatoid arthritis	0.000437	0.00806	CbGeAlD
Vandetanib—RET—digestive system—rheumatoid arthritis	0.000433	0.00799	CbGeAlD
Vandetanib—FGR—digestive system—rheumatoid arthritis	0.000433	0.00799	CbGeAlD
Vandetanib—PDGFRB—saliva-secreting gland—rheumatoid arthritis	0.000421	0.00776	CbGeAlD
Vandetanib—FGR—tendon—rheumatoid arthritis	0.000412	0.00761	CbGeAlD
Vandetanib—RET—tendon—rheumatoid arthritis	0.000412	0.00761	CbGeAlD
Vandetanib—AXL—tendon—rheumatoid arthritis	0.000411	0.00758	CbGeAlD
Vandetanib—FYN—lymphoid tissue—rheumatoid arthritis	0.000409	0.00754	CbGeAlD
Vandetanib—FYN—digestive system—rheumatoid arthritis	0.000404	0.00745	CbGeAlD
Vandetanib—MAP4K5—lymphoid tissue—rheumatoid arthritis	0.0004	0.00737	CbGeAlD
Vandetanib—TEK—lymphoid tissue—rheumatoid arthritis	0.0004	0.00737	CbGeAlD
Vandetanib—SLK—tendon—rheumatoid arthritis	0.000395	0.00729	CbGeAlD
Vandetanib—ABL1—parotid gland—rheumatoid arthritis	0.000392	0.00722	CbGeAlD
Vandetanib—PDGFRB—connective tissue—rheumatoid arthritis	0.000387	0.00713	CbGeAlD
Vandetanib—FYN—tendon—rheumatoid arthritis	0.000384	0.00709	CbGeAlD
Vandetanib—MAP4K5—tendon—rheumatoid arthritis	0.000376	0.00693	CbGeAlD
Vandetanib—TEK—tendon—rheumatoid arthritis	0.000376	0.00693	CbGeAlD
Vandetanib—ABL1—saliva-secreting gland—rheumatoid arthritis	0.000375	0.00692	CbGeAlD
Vandetanib—YES1—lymphoid tissue—rheumatoid arthritis	0.000369	0.00681	CbGeAlD
Vandetanib—STK10—lymphoid tissue—rheumatoid arthritis	0.000366	0.00675	CbGeAlD
Vandetanib—YES1—digestive system—rheumatoid arthritis	0.000365	0.00672	CbGeAlD
Vandetanib—STK10—digestive system—rheumatoid arthritis	0.000361	0.00666	CbGeAlD
Vandetanib—EPHB6—tendon—rheumatoid arthritis	0.000359	0.00662	CbGeAlD
Vandetanib—SRC—lymphoid tissue—rheumatoid arthritis	0.000355	0.00655	CbGeAlD
Vandetanib—SRC—digestive system—rheumatoid arthritis	0.000351	0.00647	CbGeAlD
Vandetanib—YES1—tendon—rheumatoid arthritis	0.000347	0.0064	CbGeAlD
Vandetanib—ABL1—connective tissue—rheumatoid arthritis	0.000345	0.00636	CbGeAlD
Vandetanib—STK10—tendon—rheumatoid arthritis	0.000344	0.00634	CbGeAlD
Vandetanib—KDR—lymphoid tissue—rheumatoid arthritis	0.000327	0.00602	CbGeAlD
Vandetanib—KDR—digestive system—rheumatoid arthritis	0.000323	0.00595	CbGeAlD
Vandetanib—MAP2K5—tendon—rheumatoid arthritis	0.000307	0.00566	CbGeAlD
Vandetanib—KDR—tendon—rheumatoid arthritis	0.000307	0.00566	CbGeAlD
Vandetanib—Bosutinib—BLK—rheumatoid arthritis	0.000301	0.0453	CrCbGaD
Vandetanib—ABCC1—parotid gland—rheumatoid arthritis	0.000298	0.0055	CbGeAlD
Vandetanib—PDGFRB—lymphoid tissue—rheumatoid arthritis	0.000283	0.00521	CbGeAlD
Vandetanib—PDGFRB—digestive system—rheumatoid arthritis	0.000279	0.00515	CbGeAlD
Vandetanib—PDGFRB—tendon—rheumatoid arthritis	0.000266	0.0049	CbGeAlD
Vandetanib—ABL1—lymphoid tissue—rheumatoid arthritis	0.000252	0.00465	CbGeAlD
Vandetanib—ABL1—digestive system—rheumatoid arthritis	0.000249	0.00459	CbGeAlD
Vandetanib—ABCG2—parotid gland—rheumatoid arthritis	0.000247	0.00455	CbGeAlD
Vandetanib—ABL1—tendon—rheumatoid arthritis	0.000237	0.00437	CbGeAlD
Vandetanib—ABCG2—saliva-secreting gland—rheumatoid arthritis	0.000236	0.00436	CbGeAlD
Vandetanib—ABCC1—tendon—rheumatoid arthritis	0.00018	0.00333	CbGeAlD
Vandetanib—VEGFA—Dexamethasone—Hydrocortisone—rheumatoid arthritis	0.000148	0.0912	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Hydrocortisone—rheumatoid arthritis	0.000148	0.0912	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Methylprednisolone—rheumatoid arthritis	0.00014	0.0861	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Methylprednisolone—rheumatoid arthritis	0.00014	0.0861	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Betamethasone—rheumatoid arthritis	0.000137	0.0847	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Dexamethasone—rheumatoid arthritis	0.000137	0.0847	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Triamcinolone—rheumatoid arthritis	0.000134	0.0828	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Triamcinolone—rheumatoid arthritis	0.000134	0.0828	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Prednisone—rheumatoid arthritis	0.000127	0.0785	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Prednisone—rheumatoid arthritis	0.000127	0.0785	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Prednisolone—rheumatoid arthritis	0.000124	0.0767	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Prednisolone—rheumatoid arthritis	0.000124	0.0767	CbGdCrCtD
Vandetanib—CYP3A4—digestive system—rheumatoid arthritis	0.000109	0.00202	CbGeAlD
Vandetanib—Hypertension—Methylprednisolone—rheumatoid arthritis	7.11e-05	0.000643	CcSEcCtD
Vandetanib—Infection—Hydrocortisone—rheumatoid arthritis	7.1e-05	0.000643	CcSEcCtD
Vandetanib—Dyspepsia—Cyclosporine—rheumatoid arthritis	7.08e-05	0.000641	CcSEcCtD
Vandetanib—Vomiting—Azathioprine—rheumatoid arthritis	7.02e-05	0.000635	CcSEcCtD
Vandetanib—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	7.01e-05	0.000635	CcSEcCtD
Vandetanib—Pneumonia—Methotrexate—rheumatoid arthritis	7.01e-05	0.000635	CcSEcCtD
Vandetanib—Arthralgia—Methylprednisolone—rheumatoid arthritis	7.01e-05	0.000634	CcSEcCtD
Vandetanib—Eye disorder—Prednisone—rheumatoid arthritis	7e-05	0.000633	CcSEcCtD
Vandetanib—Decreased appetite—Cyclosporine—rheumatoid arthritis	6.99e-05	0.000633	CcSEcCtD
Vandetanib—Anxiety—Methylprednisolone—rheumatoid arthritis	6.98e-05	0.000632	CcSEcCtD
Vandetanib—Erlotinib—ALB—rheumatoid arthritis	6.97e-05	0.0105	CrCbGaD
Vandetanib—Infestation NOS—Methotrexate—rheumatoid arthritis	6.97e-05	0.000631	CcSEcCtD
Vandetanib—Infestation—Methotrexate—rheumatoid arthritis	6.97e-05	0.000631	CcSEcCtD
Vandetanib—Rash—Azathioprine—rheumatoid arthritis	6.96e-05	0.00063	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	6.96e-05	0.00063	CcSEcCtD
Vandetanib—Dermatitis—Azathioprine—rheumatoid arthritis	6.95e-05	0.000629	CcSEcCtD
Vandetanib—Depression—Methotrexate—rheumatoid arthritis	6.95e-05	0.000629	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	6.95e-05	0.000629	CcSEcCtD
Vandetanib—Skin disorder—Hydrocortisone—rheumatoid arthritis	6.95e-05	0.000629	CcSEcCtD
Vandetanib—Fatigue—Cyclosporine—rheumatoid arthritis	6.94e-05	0.000628	CcSEcCtD
Vandetanib—Headache—Azathioprine—rheumatoid arthritis	6.92e-05	0.000626	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Methotrexate—rheumatoid arthritis	6.91e-05	0.000625	CcSEcCtD
Vandetanib—Dizziness—Leflunomide—rheumatoid arthritis	6.89e-05	0.000624	CcSEcCtD
Vandetanib—Pain—Cyclosporine—rheumatoid arthritis	6.88e-05	0.000623	CcSEcCtD
Vandetanib—Constipation—Cyclosporine—rheumatoid arthritis	6.88e-05	0.000623	CcSEcCtD
Vandetanib—Dry mouth—Triamcinolone—rheumatoid arthritis	6.87e-05	0.000622	CcSEcCtD
Vandetanib—Renal failure—Methotrexate—rheumatoid arthritis	6.85e-05	0.00062	CcSEcCtD
Vandetanib—Stomatitis—Methotrexate—rheumatoid arthritis	6.79e-05	0.000615	CcSEcCtD
Vandetanib—Angiopathy—Prednisone—rheumatoid arthritis	6.79e-05	0.000615	CcSEcCtD
Vandetanib—Conjunctivitis—Methotrexate—rheumatoid arthritis	6.78e-05	0.000613	CcSEcCtD
Vandetanib—Oedema—Triamcinolone—rheumatoid arthritis	6.73e-05	0.000609	CcSEcCtD
Vandetanib—Arrhythmia—Prednisone—rheumatoid arthritis	6.69e-05	0.000605	CcSEcCtD
Vandetanib—Infection—Triamcinolone—rheumatoid arthritis	6.69e-05	0.000605	CcSEcCtD
Vandetanib—Infection—Methylprednisolone—rheumatoid arthritis	6.67e-05	0.000604	CcSEcCtD
Vandetanib—Haematuria—Methotrexate—rheumatoid arthritis	6.65e-05	0.000602	CcSEcCtD
Vandetanib—Vomiting—Leflunomide—rheumatoid arthritis	6.63e-05	0.0006	CcSEcCtD
Vandetanib—Insomnia—Prednisolone—rheumatoid arthritis	6.62e-05	0.000599	CcSEcCtD
Vandetanib—Alopecia—Prednisone—rheumatoid arthritis	6.62e-05	0.000599	CcSEcCtD
Vandetanib—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	6.59e-05	0.000597	CcSEcCtD
Vandetanib—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	6.59e-05	0.000596	CcSEcCtD
Vandetanib—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	6.58e-05	0.000595	CcSEcCtD
Vandetanib—Loss of consciousness—Dexamethasone—rheumatoid arthritis	6.58e-05	0.000595	CcSEcCtD
Vandetanib—Loss of consciousness—Betamethasone—rheumatoid arthritis	6.58e-05	0.000595	CcSEcCtD
Vandetanib—Epistaxis—Methotrexate—rheumatoid arthritis	6.58e-05	0.000595	CcSEcCtD
Vandetanib—Paraesthesia—Prednisolone—rheumatoid arthritis	6.57e-05	0.000595	CcSEcCtD
Vandetanib—Rash—Leflunomide—rheumatoid arthritis	6.57e-05	0.000595	CcSEcCtD
Vandetanib—Dermatitis—Leflunomide—rheumatoid arthritis	6.57e-05	0.000594	CcSEcCtD
Vandetanib—Mental disorder—Prednisone—rheumatoid arthritis	6.56e-05	0.000594	CcSEcCtD
Vandetanib—Nausea—Azathioprine—rheumatoid arthritis	6.56e-05	0.000593	CcSEcCtD
Vandetanib—Headache—Leflunomide—rheumatoid arthritis	6.53e-05	0.000591	CcSEcCtD
Vandetanib—Skin disorder—Methylprednisolone—rheumatoid arthritis	6.52e-05	0.00059	CcSEcCtD
Vandetanib—Malnutrition—Prednisone—rheumatoid arthritis	6.52e-05	0.00059	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	6.51e-05	0.00059	CcSEcCtD
Vandetanib—Convulsion—Dexamethasone—rheumatoid arthritis	6.49e-05	0.000587	CcSEcCtD
Vandetanib—Convulsion—Betamethasone—rheumatoid arthritis	6.49e-05	0.000587	CcSEcCtD
Vandetanib—Insomnia—Hydrocortisone—rheumatoid arthritis	6.47e-05	0.000585	CcSEcCtD
Vandetanib—Hypertension—Dexamethasone—rheumatoid arthritis	6.46e-05	0.000585	CcSEcCtD
Vandetanib—Hypertension—Betamethasone—rheumatoid arthritis	6.46e-05	0.000585	CcSEcCtD
Vandetanib—Paraesthesia—Hydrocortisone—rheumatoid arthritis	6.42e-05	0.000581	CcSEcCtD
Vandetanib—Abdominal pain—Cyclosporine—rheumatoid arthritis	6.36e-05	0.000576	CcSEcCtD
Vandetanib—Body temperature increased—Cyclosporine—rheumatoid arthritis	6.36e-05	0.000576	CcSEcCtD
Vandetanib—Anxiety—Dexamethasone—rheumatoid arthritis	6.35e-05	0.000575	CcSEcCtD
Vandetanib—Anxiety—Betamethasone—rheumatoid arthritis	6.35e-05	0.000575	CcSEcCtD
Vandetanib—Dyspepsia—Hydrocortisone—rheumatoid arthritis	6.29e-05	0.00057	CcSEcCtD
Vandetanib—Haemoglobin—Methotrexate—rheumatoid arthritis	6.29e-05	0.000569	CcSEcCtD
Vandetanib—Pain—Prednisolone—rheumatoid arthritis	6.26e-05	0.000567	CcSEcCtD
Vandetanib—Haemorrhage—Methotrexate—rheumatoid arthritis	6.26e-05	0.000566	CcSEcCtD
Vandetanib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	6.22e-05	0.000562	CcSEcCtD
Vandetanib—Nausea—Leflunomide—rheumatoid arthritis	6.19e-05	0.00056	CcSEcCtD
Vandetanib—Urinary tract disorder—Methotrexate—rheumatoid arthritis	6.18e-05	0.000559	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	6.17e-05	0.000559	CcSEcCtD
Vandetanib—Fatigue—Hydrocortisone—rheumatoid arthritis	6.16e-05	0.000558	CcSEcCtD
Vandetanib—Vision blurred—Prednisone—rheumatoid arthritis	6.14e-05	0.000556	CcSEcCtD
Vandetanib—Urethral disorder—Methotrexate—rheumatoid arthritis	6.13e-05	0.000555	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	6.13e-05	0.000555	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	6.12e-05	0.000554	CcSEcCtD
Vandetanib—Pain—Hydrocortisone—rheumatoid arthritis	6.11e-05	0.000553	CcSEcCtD
Vandetanib—Oedema—Dexamethasone—rheumatoid arthritis	6.11e-05	0.000553	CcSEcCtD
Vandetanib—Oedema—Betamethasone—rheumatoid arthritis	6.11e-05	0.000553	CcSEcCtD
Vandetanib—Insomnia—Triamcinolone—rheumatoid arthritis	6.09e-05	0.000551	CcSEcCtD
Vandetanib—Insomnia—Methylprednisolone—rheumatoid arthritis	6.08e-05	0.00055	CcSEcCtD
Vandetanib—Infection—Dexamethasone—rheumatoid arthritis	6.07e-05	0.000549	CcSEcCtD
Vandetanib—Infection—Betamethasone—rheumatoid arthritis	6.07e-05	0.000549	CcSEcCtD
Vandetanib—Paraesthesia—Triamcinolone—rheumatoid arthritis	6.05e-05	0.000547	CcSEcCtD
Vandetanib—Paraesthesia—Methylprednisolone—rheumatoid arthritis	6.03e-05	0.000546	CcSEcCtD
Vandetanib—Visual impairment—Methotrexate—rheumatoid arthritis	6.03e-05	0.000546	CcSEcCtD
Vandetanib—Dyspnoea—Triamcinolone—rheumatoid arthritis	6e-05	0.000543	CcSEcCtD
Vandetanib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	5.99e-05	0.000542	CcSEcCtD
Vandetanib—Nervous system disorder—Betamethasone—rheumatoid arthritis	5.99e-05	0.000542	CcSEcCtD
Vandetanib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	5.98e-05	0.000541	CcSEcCtD
Vandetanib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	5.98e-05	0.000541	CcSEcCtD
Vandetanib—Dyspepsia—Triamcinolone—rheumatoid arthritis	5.93e-05	0.000536	CcSEcCtD
Vandetanib—Erythema multiforme—Methotrexate—rheumatoid arthritis	5.92e-05	0.000535	CcSEcCtD
Vandetanib—Dyspepsia—Methylprednisolone—rheumatoid arthritis	5.91e-05	0.000535	CcSEcCtD
Vandetanib—Eye disorder—Methotrexate—rheumatoid arthritis	5.85e-05	0.000529	CcSEcCtD
Vandetanib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	5.85e-05	0.000529	CcSEcCtD
Vandetanib—Cardiac disorder—Methotrexate—rheumatoid arthritis	5.81e-05	0.000526	CcSEcCtD
Vandetanib—Fatigue—Triamcinolone—rheumatoid arthritis	5.8e-05	0.000525	CcSEcCtD
Vandetanib—Fatigue—Methylprednisolone—rheumatoid arthritis	5.79e-05	0.000524	CcSEcCtD
Vandetanib—Asthenia—Cyclosporine—rheumatoid arthritis	5.77e-05	0.000522	CcSEcCtD
Vandetanib—Pain—Triamcinolone—rheumatoid arthritis	5.76e-05	0.000521	CcSEcCtD
Vandetanib—Loss of consciousness—Prednisone—rheumatoid arthritis	5.73e-05	0.000518	CcSEcCtD
Vandetanib—Pruritus—Cyclosporine—rheumatoid arthritis	5.69e-05	0.000515	CcSEcCtD
Vandetanib—Angiopathy—Methotrexate—rheumatoid arthritis	5.68e-05	0.000514	CcSEcCtD
Vandetanib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	5.65e-05	0.000512	CcSEcCtD
Vandetanib—Body temperature increased—Hydrocortisone—rheumatoid arthritis	5.65e-05	0.000512	CcSEcCtD
Vandetanib—Convulsion—Prednisone—rheumatoid arthritis	5.65e-05	0.000511	CcSEcCtD
Vandetanib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	5.64e-05	0.00051	CcSEcCtD
Vandetanib—Hypertension—Prednisone—rheumatoid arthritis	5.63e-05	0.000509	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	5.57e-05	0.000504	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	5.57e-05	0.000504	CcSEcCtD
Vandetanib—Arthralgia—Prednisone—rheumatoid arthritis	5.55e-05	0.000502	CcSEcCtD
Vandetanib—Anxiety—Prednisone—rheumatoid arthritis	5.53e-05	0.0005	CcSEcCtD
Vandetanib—Alopecia—Methotrexate—rheumatoid arthritis	5.53e-05	0.0005	CcSEcCtD
Vandetanib—Insomnia—Dexamethasone—rheumatoid arthritis	5.53e-05	0.0005	CcSEcCtD
Vandetanib—Insomnia—Betamethasone—rheumatoid arthritis	5.53e-05	0.0005	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	5.51e-05	0.000499	CcSEcCtD
Vandetanib—Diarrhoea—Cyclosporine—rheumatoid arthritis	5.5e-05	0.000498	CcSEcCtD
Vandetanib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	5.49e-05	0.000497	CcSEcCtD
Vandetanib—Paraesthesia—Dexamethasone—rheumatoid arthritis	5.49e-05	0.000496	CcSEcCtD
Vandetanib—Paraesthesia—Betamethasone—rheumatoid arthritis	5.49e-05	0.000496	CcSEcCtD
Vandetanib—Mental disorder—Methotrexate—rheumatoid arthritis	5.48e-05	0.000496	CcSEcCtD
Vandetanib—Malnutrition—Methotrexate—rheumatoid arthritis	5.45e-05	0.000493	CcSEcCtD
Vandetanib—Dyspepsia—Dexamethasone—rheumatoid arthritis	5.38e-05	0.000487	CcSEcCtD
Vandetanib—Dyspepsia—Betamethasone—rheumatoid arthritis	5.38e-05	0.000487	CcSEcCtD
Vandetanib—Dysgeusia—Methotrexate—rheumatoid arthritis	5.33e-05	0.000483	CcSEcCtD
Vandetanib—Body temperature increased—Triamcinolone—rheumatoid arthritis	5.32e-05	0.000482	CcSEcCtD
Vandetanib—Dizziness—Cyclosporine—rheumatoid arthritis	5.32e-05	0.000481	CcSEcCtD
Vandetanib—Oedema—Prednisone—rheumatoid arthritis	5.32e-05	0.000481	CcSEcCtD
Vandetanib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	5.31e-05	0.000481	CcSEcCtD
Vandetanib—Decreased appetite—Dexamethasone—rheumatoid arthritis	5.31e-05	0.000481	CcSEcCtD
Vandetanib—Decreased appetite—Betamethasone—rheumatoid arthritis	5.31e-05	0.000481	CcSEcCtD
Vandetanib—Infection—Prednisone—rheumatoid arthritis	5.29e-05	0.000478	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	5.27e-05	0.000477	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	5.27e-05	0.000477	CcSEcCtD
Vandetanib—Fatigue—Betamethasone—rheumatoid arthritis	5.27e-05	0.000477	CcSEcCtD
Vandetanib—Fatigue—Dexamethasone—rheumatoid arthritis	5.27e-05	0.000477	CcSEcCtD
Vandetanib—Pain—Betamethasone—rheumatoid arthritis	5.22e-05	0.000473	CcSEcCtD
Vandetanib—Pain—Dexamethasone—rheumatoid arthritis	5.22e-05	0.000473	CcSEcCtD
Vandetanib—Nervous system disorder—Prednisone—rheumatoid arthritis	5.22e-05	0.000472	CcSEcCtD
Vandetanib—Skin disorder—Prednisone—rheumatoid arthritis	5.17e-05	0.000468	CcSEcCtD
Vandetanib—Vision blurred—Methotrexate—rheumatoid arthritis	5.13e-05	0.000465	CcSEcCtD
Vandetanib—Asthenia—Hydrocortisone—rheumatoid arthritis	5.13e-05	0.000464	CcSEcCtD
Vandetanib—Vomiting—Cyclosporine—rheumatoid arthritis	5.12e-05	0.000463	CcSEcCtD
Vandetanib—Rash—Cyclosporine—rheumatoid arthritis	5.07e-05	0.000459	CcSEcCtD
Vandetanib—Dermatitis—Cyclosporine—rheumatoid arthritis	5.07e-05	0.000459	CcSEcCtD
Vandetanib—Pruritus—Hydrocortisone—rheumatoid arthritis	5.06e-05	0.000458	CcSEcCtD
Vandetanib—Headache—Cyclosporine—rheumatoid arthritis	5.04e-05	0.000456	CcSEcCtD
Vandetanib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	5e-05	0.000452	CcSEcCtD
Vandetanib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	5e-05	0.000452	CcSEcCtD
Vandetanib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	4.89e-05	0.000443	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	4.85e-05	0.000439	CcSEcCtD
Vandetanib—Dizziness—Prednisolone—rheumatoid arthritis	4.84e-05	0.000438	CcSEcCtD
Vandetanib—Asthenia—Triamcinolone—rheumatoid arthritis	4.83e-05	0.000437	CcSEcCtD
Vandetanib—Body temperature increased—Betamethasone—rheumatoid arthritis	4.83e-05	0.000437	CcSEcCtD
Vandetanib—Body temperature increased—Dexamethasone—rheumatoid arthritis	4.83e-05	0.000437	CcSEcCtD
Vandetanib—Abdominal pain—Betamethasone—rheumatoid arthritis	4.83e-05	0.000437	CcSEcCtD
Vandetanib—Abdominal pain—Dexamethasone—rheumatoid arthritis	4.83e-05	0.000437	CcSEcCtD
Vandetanib—Asthenia—Methylprednisolone—rheumatoid arthritis	4.82e-05	0.000436	CcSEcCtD
Vandetanib—Insomnia—Prednisone—rheumatoid arthritis	4.81e-05	0.000435	CcSEcCtD
Vandetanib—Nausea—Cyclosporine—rheumatoid arthritis	4.78e-05	0.000432	CcSEcCtD
Vandetanib—Paraesthesia—Prednisone—rheumatoid arthritis	4.78e-05	0.000432	CcSEcCtD
Vandetanib—Pruritus—Triamcinolone—rheumatoid arthritis	4.76e-05	0.000431	CcSEcCtD
Vandetanib—Cough—Methotrexate—rheumatoid arthritis	4.75e-05	0.00043	CcSEcCtD
Vandetanib—Pruritus—Methylprednisolone—rheumatoid arthritis	4.75e-05	0.00043	CcSEcCtD
Vandetanib—Dizziness—Hydrocortisone—rheumatoid arthritis	4.73e-05	0.000428	CcSEcCtD
Vandetanib—Convulsion—Methotrexate—rheumatoid arthritis	4.72e-05	0.000427	CcSEcCtD
Vandetanib—Dyspepsia—Prednisone—rheumatoid arthritis	4.68e-05	0.000424	CcSEcCtD
Vandetanib—Arthralgia—Methotrexate—rheumatoid arthritis	4.64e-05	0.00042	CcSEcCtD
Vandetanib—Chest pain—Methotrexate—rheumatoid arthritis	4.64e-05	0.00042	CcSEcCtD
Vandetanib—Decreased appetite—Prednisone—rheumatoid arthritis	4.62e-05	0.000419	CcSEcCtD
Vandetanib—Rash—Prednisolone—rheumatoid arthritis	4.62e-05	0.000418	CcSEcCtD
Vandetanib—Dermatitis—Prednisolone—rheumatoid arthritis	4.61e-05	0.000417	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	4.61e-05	0.000417	CcSEcCtD
Vandetanib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	4.6e-05	0.000416	CcSEcCtD
Vandetanib—Fatigue—Prednisone—rheumatoid arthritis	4.59e-05	0.000415	CcSEcCtD
Vandetanib—Headache—Prednisolone—rheumatoid arthritis	4.59e-05	0.000415	CcSEcCtD
Vandetanib—Constipation—Prednisone—rheumatoid arthritis	4.55e-05	0.000412	CcSEcCtD
Vandetanib—Vomiting—Hydrocortisone—rheumatoid arthritis	4.55e-05	0.000411	CcSEcCtD
Vandetanib—Rash—Hydrocortisone—rheumatoid arthritis	4.51e-05	0.000408	CcSEcCtD
Vandetanib—Dermatitis—Hydrocortisone—rheumatoid arthritis	4.5e-05	0.000408	CcSEcCtD
Vandetanib—Headache—Hydrocortisone—rheumatoid arthritis	4.48e-05	0.000405	CcSEcCtD
Vandetanib—Dizziness—Triamcinolone—rheumatoid arthritis	4.45e-05	0.000403	CcSEcCtD
Vandetanib—Dizziness—Methylprednisolone—rheumatoid arthritis	4.44e-05	0.000402	CcSEcCtD
Vandetanib—Infection—Methotrexate—rheumatoid arthritis	4.42e-05	0.0004	CcSEcCtD
Vandetanib—Asthenia—Betamethasone—rheumatoid arthritis	4.38e-05	0.000397	CcSEcCtD
Vandetanib—Asthenia—Dexamethasone—rheumatoid arthritis	4.38e-05	0.000397	CcSEcCtD
Vandetanib—Gefitinib—ALB—rheumatoid arthritis	4.36e-05	0.00657	CrCbGaD
Vandetanib—Nervous system disorder—Methotrexate—rheumatoid arthritis	4.36e-05	0.000395	CcSEcCtD
Vandetanib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	4.35e-05	0.000394	CcSEcCtD
Vandetanib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	4.35e-05	0.000394	CcSEcCtD
Vandetanib—Nausea—Prednisolone—rheumatoid arthritis	4.35e-05	0.000394	CcSEcCtD
Vandetanib—Pruritus—Betamethasone—rheumatoid arthritis	4.32e-05	0.000391	CcSEcCtD
Vandetanib—Pruritus—Dexamethasone—rheumatoid arthritis	4.32e-05	0.000391	CcSEcCtD
Vandetanib—Skin disorder—Methotrexate—rheumatoid arthritis	4.32e-05	0.000391	CcSEcCtD
Vandetanib—Vomiting—Triamcinolone—rheumatoid arthritis	4.28e-05	0.000387	CcSEcCtD
Vandetanib—Vomiting—Methylprednisolone—rheumatoid arthritis	4.27e-05	0.000387	CcSEcCtD
Vandetanib—Nausea—Hydrocortisone—rheumatoid arthritis	4.25e-05	0.000384	CcSEcCtD
Vandetanib—Rash—Triamcinolone—rheumatoid arthritis	4.24e-05	0.000384	CcSEcCtD
Vandetanib—Dermatitis—Triamcinolone—rheumatoid arthritis	4.24e-05	0.000384	CcSEcCtD
Vandetanib—Rash—Methylprednisolone—rheumatoid arthritis	4.24e-05	0.000383	CcSEcCtD
Vandetanib—Dermatitis—Methylprednisolone—rheumatoid arthritis	4.23e-05	0.000383	CcSEcCtD
Vandetanib—Headache—Triamcinolone—rheumatoid arthritis	4.22e-05	0.000382	CcSEcCtD
Vandetanib—Headache—Methylprednisolone—rheumatoid arthritis	4.21e-05	0.000381	CcSEcCtD
Vandetanib—Abdominal pain—Prednisone—rheumatoid arthritis	4.21e-05	0.000381	CcSEcCtD
Vandetanib—Body temperature increased—Prednisone—rheumatoid arthritis	4.21e-05	0.000381	CcSEcCtD
Vandetanib—Diarrhoea—Betamethasone—rheumatoid arthritis	4.18e-05	0.000378	CcSEcCtD
Vandetanib—Diarrhoea—Dexamethasone—rheumatoid arthritis	4.18e-05	0.000378	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	4.05e-05	0.000367	CcSEcCtD
Vandetanib—Dizziness—Betamethasone—rheumatoid arthritis	4.04e-05	0.000366	CcSEcCtD
Vandetanib—Dizziness—Dexamethasone—rheumatoid arthritis	4.04e-05	0.000366	CcSEcCtD
Vandetanib—Insomnia—Methotrexate—rheumatoid arthritis	4.02e-05	0.000364	CcSEcCtD
Vandetanib—Nausea—Triamcinolone—rheumatoid arthritis	4e-05	0.000362	CcSEcCtD
Vandetanib—Paraesthesia—Methotrexate—rheumatoid arthritis	3.99e-05	0.000361	CcSEcCtD
Vandetanib—Nausea—Methylprednisolone—rheumatoid arthritis	3.99e-05	0.000361	CcSEcCtD
Vandetanib—Dyspnoea—Methotrexate—rheumatoid arthritis	3.96e-05	0.000359	CcSEcCtD
Vandetanib—Dyspepsia—Methotrexate—rheumatoid arthritis	3.91e-05	0.000354	CcSEcCtD
Vandetanib—Vomiting—Dexamethasone—rheumatoid arthritis	3.88e-05	0.000352	CcSEcCtD
Vandetanib—Vomiting—Betamethasone—rheumatoid arthritis	3.88e-05	0.000352	CcSEcCtD
Vandetanib—Decreased appetite—Methotrexate—rheumatoid arthritis	3.86e-05	0.00035	CcSEcCtD
Vandetanib—Rash—Dexamethasone—rheumatoid arthritis	3.85e-05	0.000349	CcSEcCtD
Vandetanib—Rash—Betamethasone—rheumatoid arthritis	3.85e-05	0.000349	CcSEcCtD
Vandetanib—Dermatitis—Dexamethasone—rheumatoid arthritis	3.85e-05	0.000348	CcSEcCtD
Vandetanib—Dermatitis—Betamethasone—rheumatoid arthritis	3.85e-05	0.000348	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	3.84e-05	0.000347	CcSEcCtD
Vandetanib—Fatigue—Methotrexate—rheumatoid arthritis	3.83e-05	0.000347	CcSEcCtD
Vandetanib—Headache—Betamethasone—rheumatoid arthritis	3.83e-05	0.000346	CcSEcCtD
Vandetanib—Headache—Dexamethasone—rheumatoid arthritis	3.83e-05	0.000346	CcSEcCtD
Vandetanib—Asthenia—Prednisone—rheumatoid arthritis	3.82e-05	0.000345	CcSEcCtD
Vandetanib—Pain—Methotrexate—rheumatoid arthritis	3.8e-05	0.000344	CcSEcCtD
Vandetanib—Pruritus—Prednisone—rheumatoid arthritis	3.76e-05	0.000341	CcSEcCtD
Vandetanib—Diarrhoea—Prednisone—rheumatoid arthritis	3.64e-05	0.000329	CcSEcCtD
Vandetanib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	3.64e-05	0.000329	CcSEcCtD
Vandetanib—Nausea—Dexamethasone—rheumatoid arthritis	3.63e-05	0.000328	CcSEcCtD
Vandetanib—Nausea—Betamethasone—rheumatoid arthritis	3.63e-05	0.000328	CcSEcCtD
Vandetanib—Dizziness—Prednisone—rheumatoid arthritis	3.52e-05	0.000318	CcSEcCtD
Vandetanib—Abdominal pain—Methotrexate—rheumatoid arthritis	3.51e-05	0.000318	CcSEcCtD
Vandetanib—Body temperature increased—Methotrexate—rheumatoid arthritis	3.51e-05	0.000318	CcSEcCtD
Vandetanib—Vomiting—Prednisone—rheumatoid arthritis	3.38e-05	0.000306	CcSEcCtD
Vandetanib—Rash—Prednisone—rheumatoid arthritis	3.35e-05	0.000304	CcSEcCtD
Vandetanib—Dermatitis—Prednisone—rheumatoid arthritis	3.35e-05	0.000303	CcSEcCtD
Vandetanib—Headache—Prednisone—rheumatoid arthritis	3.33e-05	0.000302	CcSEcCtD
Vandetanib—Asthenia—Methotrexate—rheumatoid arthritis	3.19e-05	0.000289	CcSEcCtD
Vandetanib—Nausea—Prednisone—rheumatoid arthritis	3.16e-05	0.000286	CcSEcCtD
Vandetanib—Pruritus—Methotrexate—rheumatoid arthritis	3.15e-05	0.000285	CcSEcCtD
Vandetanib—Diarrhoea—Methotrexate—rheumatoid arthritis	3.04e-05	0.000275	CcSEcCtD
Vandetanib—Dizziness—Methotrexate—rheumatoid arthritis	2.94e-05	0.000266	CcSEcCtD
Vandetanib—Vomiting—Methotrexate—rheumatoid arthritis	2.83e-05	0.000256	CcSEcCtD
Vandetanib—Rash—Methotrexate—rheumatoid arthritis	2.8e-05	0.000254	CcSEcCtD
Vandetanib—Dermatitis—Methotrexate—rheumatoid arthritis	2.8e-05	0.000253	CcSEcCtD
Vandetanib—Headache—Methotrexate—rheumatoid arthritis	2.79e-05	0.000252	CcSEcCtD
Vandetanib—Nausea—Methotrexate—rheumatoid arthritis	2.64e-05	0.000239	CcSEcCtD
Vandetanib—ABCC1—Metabolism—POMC—rheumatoid arthritis	1.36e-06	7.88e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—TYK2—rheumatoid arthritis	1.36e-06	7.88e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MAPK8—rheumatoid arthritis	1.36e-06	7.87e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SPP1—rheumatoid arthritis	1.36e-06	7.87e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6ST—rheumatoid arthritis	1.36e-06	7.86e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—MAPK8—rheumatoid arthritis	1.35e-06	7.85e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CD80—rheumatoid arthritis	1.35e-06	7.85e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CXCL8—rheumatoid arthritis	1.35e-06	7.84e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2RA—rheumatoid arthritis	1.35e-06	7.83e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—NFKB1—rheumatoid arthritis	1.35e-06	7.82e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—NFKB1—rheumatoid arthritis	1.35e-06	7.81e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MMP9—rheumatoid arthritis	1.35e-06	7.8e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—IL2—rheumatoid arthritis	1.35e-06	7.8e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—NFKB1—rheumatoid arthritis	1.34e-06	7.78e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL2—rheumatoid arthritis	1.34e-06	7.77e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—C3—rheumatoid arthritis	1.34e-06	7.76e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—NOS3—rheumatoid arthritis	1.33e-06	7.73e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—NFKB1—rheumatoid arthritis	1.33e-06	7.72e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD4—rheumatoid arthritis	1.33e-06	7.72e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—IFNG—rheumatoid arthritis	1.33e-06	7.7e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—NFKB1—rheumatoid arthritis	1.33e-06	7.7e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—MAPK8—rheumatoid arthritis	1.33e-06	7.68e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CD80—rheumatoid arthritis	1.33e-06	7.68e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MAPK8—rheumatoid arthritis	1.32e-06	7.67e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PTK2—rheumatoid arthritis	1.32e-06	7.67e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.32e-06	7.66e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCR5—rheumatoid arthritis	1.32e-06	7.66e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MED1—rheumatoid arthritis	1.32e-06	7.65e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—MAPK8—rheumatoid arthritis	1.32e-06	7.65e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—TYK2—rheumatoid arthritis	1.31e-06	7.59e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MAPK8—rheumatoid arthritis	1.31e-06	7.59e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.31e-06	7.57e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—MAPK8—rheumatoid arthritis	1.31e-06	7.56e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CD80—rheumatoid arthritis	1.31e-06	7.56e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CD4—rheumatoid arthritis	1.3e-06	7.56e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2RA—rheumatoid arthritis	1.3e-06	7.55e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL5—rheumatoid arthritis	1.3e-06	7.52e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PTGS2—rheumatoid arthritis	1.29e-06	7.5e-06	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL6—rheumatoid arthritis	1.29e-06	7.5e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL2—rheumatoid arthritis	1.29e-06	7.49e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—C3—rheumatoid arthritis	1.29e-06	7.48e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—POMC—rheumatoid arthritis	1.29e-06	7.46e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—NOS3—rheumatoid arthritis	1.29e-06	7.45e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD4—rheumatoid arthritis	1.28e-06	7.44e-06	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—TP53—rheumatoid arthritis	1.28e-06	7.42e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CSF2—rheumatoid arthritis	1.28e-06	7.41e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—IL6R—rheumatoid arthritis	1.27e-06	7.38e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—POMC—rheumatoid arthritis	1.26e-06	7.3e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.26e-06	7.3e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCL2—rheumatoid arthritis	1.26e-06	7.3e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—TYK2—rheumatoid arthritis	1.26e-06	7.28e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL6R—rheumatoid arthritis	1.25e-06	7.27e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—VEGFA—rheumatoid arthritis	1.25e-06	7.27e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL2—rheumatoid arthritis	1.25e-06	7.24e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—LEP—rheumatoid arthritis	1.25e-06	7.23e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—POMC—rheumatoid arthritis	1.24e-06	7.19e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ALB—rheumatoid arthritis	1.24e-06	7.18e-06	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—IL6—rheumatoid arthritis	1.24e-06	7.17e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCL2—rheumatoid arthritis	1.23e-06	7.14e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL1B—rheumatoid arthritis	1.23e-06	7.13e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD4—rheumatoid arthritis	1.23e-06	7.12e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6R—rheumatoid arthritis	1.23e-06	7.12e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	1.23e-06	7.12e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	1.23e-06	7.12e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL2—rheumatoid arthritis	1.22e-06	7.1e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP9—rheumatoid arthritis	1.22e-06	7.09e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—VEGFA—rheumatoid arthritis	1.22e-06	7.08e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTGS2—rheumatoid arthritis	1.22e-06	7.07e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCL2—rheumatoid arthritis	1.21e-06	7.03e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—NFKB1—rheumatoid arthritis	1.21e-06	7.02e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6R—rheumatoid arthritis	1.21e-06	7.01e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—VEGFA—rheumatoid arthritis	1.21e-06	7.01e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SPP1—rheumatoid arthritis	1.2e-06	6.97e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—LEP—rheumatoid arthritis	1.2e-06	6.97e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—POMC—rheumatoid arthritis	1.2e-06	6.93e-06	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—IL6—rheumatoid arthritis	1.19e-06	6.92e-06	CbGpPWpGaD
Vandetanib—ERBB3—Disease—IL6—rheumatoid arthritis	1.19e-06	6.92e-06	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—IL6—rheumatoid arthritis	1.19e-06	6.9e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MAPK8—rheumatoid arthritis	1.19e-06	6.9e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—NOS3—rheumatoid arthritis	1.19e-06	6.87e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL1B—rheumatoid arthritis	1.18e-06	6.87e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—CD4—rheumatoid arthritis	1.18e-06	6.87e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP9—rheumatoid arthritis	1.18e-06	6.85e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL2—rheumatoid arthritis	1.18e-06	6.84e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IFNG—rheumatoid arthritis	1.18e-06	6.82e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—FN1—rheumatoid arthritis	1.18e-06	6.82e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—PTGS2—rheumatoid arthritis	1.18e-06	6.82e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6ST—rheumatoid arthritis	1.17e-06	6.79e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCR5—rheumatoid arthritis	1.17e-06	6.78e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.17e-06	6.78e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—TYK2—rheumatoid arthritis	1.16e-06	6.72e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2RA—rheumatoid arthritis	1.15e-06	6.68e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TGFB1—rheumatoid arthritis	1.15e-06	6.67e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.15e-06	6.66e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—NFKB1—rheumatoid arthritis	1.15e-06	6.65e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—VEGFA—rheumatoid arthritis	1.14e-06	6.63e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TYK2—rheumatoid arthritis	1.14e-06	6.62e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—C3—rheumatoid arthritis	1.14e-06	6.62e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—NOS3—rheumatoid arthritis	1.14e-06	6.6e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD4—rheumatoid arthritis	1.14e-06	6.58e-06	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL6—rheumatoid arthritis	1.14e-06	6.58e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—FN1—rheumatoid arthritis	1.13e-06	6.57e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6ST—rheumatoid arthritis	1.13e-06	6.54e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—MAPK8—rheumatoid arthritis	1.13e-06	6.54e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CD80—rheumatoid arthritis	1.13e-06	6.53e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NOS3—rheumatoid arthritis	1.12e-06	6.5e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TGFB1—rheumatoid arthritis	1.12e-06	6.5e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TYK2—rheumatoid arthritis	1.12e-06	6.49e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.11e-06	6.43e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CAT—rheumatoid arthritis	1.11e-06	6.41e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—NFKB1—rheumatoid arthritis	1.11e-06	6.41e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	1.11e-06	6.41e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TYK2—rheumatoid arthritis	1.1e-06	6.39e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NOS3—rheumatoid arthritis	1.1e-06	6.37e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ALB—rheumatoid arthritis	1.09e-06	6.32e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—MAPK8—rheumatoid arthritis	1.09e-06	6.3e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CD80—rheumatoid arthritis	1.09e-06	6.3e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTGS2—rheumatoid arthritis	1.08e-06	6.28e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NOS3—rheumatoid arthritis	1.08e-06	6.27e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—POMC—rheumatoid arthritis	1.07e-06	6.21e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—LEP—rheumatoid arthritis	1.06e-06	6.17e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.06e-06	6.15e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—TGFB1—rheumatoid arthritis	1.06e-06	6.14e-06	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—IL6—rheumatoid arthritis	1.05e-06	6.11e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TGFB1—rheumatoid arthritis	1.05e-06	6.08e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL1B—rheumatoid arthritis	1.05e-06	6.08e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—CD4—rheumatoid arthritis	1.05e-06	6.08e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCL2—rheumatoid arthritis	1.05e-06	6.08e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL2—rheumatoid arthritis	1.05e-06	6.06e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6R—rheumatoid arthritis	1.04e-06	6.06e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—NOS3—rheumatoid arthritis	1.04e-06	6.05e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—PTGS2—rheumatoid arthritis	1.04e-06	6.03e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TP53—rheumatoid arthritis	1.04e-06	6.01e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—POMC—rheumatoid arthritis	1.03e-06	5.98e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—TGFB1—rheumatoid arthritis	1.02e-06	5.92e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.02e-06	5.9e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCL2—rheumatoid arthritis	1.01e-06	5.85e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TGFB1—rheumatoid arthritis	1.01e-06	5.84e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6R—rheumatoid arthritis	1.01e-06	5.84e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—FN1—rheumatoid arthritis	1e-06	5.82e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6ST—rheumatoid arthritis	9.99e-07	5.79e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CXCL8—rheumatoid arthritis	9.95e-07	5.77e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—NFKB1—rheumatoid arthritis	9.79e-07	5.67e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CXCL8—rheumatoid arthritis	9.74e-07	5.65e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TGFB1—rheumatoid arthritis	9.74e-07	5.65e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—MAPK8—rheumatoid arthritis	9.62e-07	5.58e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CD80—rheumatoid arthritis	9.62e-07	5.58e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CXCL8—rheumatoid arthritis	9.59e-07	5.56e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTGS2—rheumatoid arthritis	9.54e-07	5.53e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TYK2—rheumatoid arthritis	9.52e-07	5.52e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL2—rheumatoid arthritis	9.51e-07	5.51e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL6—rheumatoid arthritis	9.48e-07	5.5e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TP53—rheumatoid arthritis	9.48e-07	5.49e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—TGFB1—rheumatoid arthritis	9.36e-07	5.42e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NOS3—rheumatoid arthritis	9.34e-07	5.41e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL2—rheumatoid arthritis	9.31e-07	5.4e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TP53—rheumatoid arthritis	9.24e-07	5.35e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—MTHFR—rheumatoid arthritis	9.23e-07	5.35e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TYK2—rheumatoid arthritis	9.17e-07	5.32e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL2—rheumatoid arthritis	9.17e-07	5.31e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—POMC—rheumatoid arthritis	9.14e-07	5.3e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TP53—rheumatoid arthritis	9.13e-07	5.29e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NOS3—rheumatoid arthritis	9e-07	5.22e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP9—rheumatoid arthritis	9e-07	5.22e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL2—rheumatoid arthritis	8.94e-07	5.18e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6R—rheumatoid arthritis	8.92e-07	5.17e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NFKB1—rheumatoid arthritis	8.91e-07	5.16e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—TGFB1—rheumatoid arthritis	8.82e-07	5.11e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP9—rheumatoid arthritis	8.81e-07	5.11e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MAPK8—rheumatoid arthritis	8.75e-07	5.07e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NFKB1—rheumatoid arthritis	8.72e-07	5.05e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP9—rheumatoid arthritis	8.68e-07	5.03e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL6—rheumatoid arthritis	8.67e-07	5.03e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL6—rheumatoid arthritis	8.65e-07	5.01e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TP53—rheumatoid arthritis	8.64e-07	5.01e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NFKB1—rheumatoid arthritis	8.58e-07	4.98e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MAPK8—rheumatoid arthritis	8.57e-07	4.97e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—TGFB1—rheumatoid arthritis	8.5e-07	4.93e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL6—rheumatoid arthritis	8.46e-07	4.91e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL6—rheumatoid arthritis	8.45e-07	4.9e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MAPK8—rheumatoid arthritis	8.44e-07	4.89e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL6—rheumatoid arthritis	8.43e-07	4.88e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL6—rheumatoid arthritis	8.36e-07	4.85e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL6—rheumatoid arthritis	8.33e-07	4.83e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TP53—rheumatoid arthritis	8.3e-07	4.81e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	8.29e-07	4.81e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CXCL8—rheumatoid arthritis	8.29e-07	4.8e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TYK2—rheumatoid arthritis	8.12e-07	4.71e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—VEGFA—rheumatoid arthritis	8.08e-07	4.68e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TP53—rheumatoid arthritis	8.02e-07	4.65e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CXCL8—rheumatoid arthritis	7.99e-07	4.63e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—IL6—rheumatoid arthritis	7.98e-07	4.63e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NOS3—rheumatoid arthritis	7.97e-07	4.62e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2—rheumatoid arthritis	7.92e-07	4.59e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—VEGFA—rheumatoid arthritis	7.91e-07	4.59e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL6—rheumatoid arthritis	7.88e-07	4.57e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—VEGFA—rheumatoid arthritis	7.79e-07	4.52e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—IL6—rheumatoid arthritis	7.69e-07	4.46e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2—rheumatoid arthritis	7.63e-07	4.42e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL6—rheumatoid arthritis	7.6e-07	4.4e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—TGFB1—rheumatoid arthritis	7.53e-07	4.36e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP9—rheumatoid arthritis	7.5e-07	4.34e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TGFB1—rheumatoid arthritis	7.42e-07	4.3e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NFKB1—rheumatoid arthritis	7.42e-07	4.3e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—POMC—rheumatoid arthritis	7.38e-07	4.28e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL6—rheumatoid arthritis	7.34e-07	4.25e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MAPK8—rheumatoid arthritis	7.29e-07	4.23e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TGFB1—rheumatoid arthritis	7.26e-07	4.21e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP9—rheumatoid arthritis	7.22e-07	4.19e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL6—rheumatoid arthritis	7.2e-07	4.17e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TGFB1—rheumatoid arthritis	7.15e-07	4.14e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NFKB1—rheumatoid arthritis	7.15e-07	4.14e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CXCL8—rheumatoid arthritis	7.07e-07	4.1e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—IL6—rheumatoid arthritis	7.05e-07	4.09e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MAPK8—rheumatoid arthritis	7.02e-07	4.07e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL6—rheumatoid arthritis	6.94e-07	4.02e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2—rheumatoid arthritis	6.76e-07	3.92e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—VEGFA—rheumatoid arthritis	6.73e-07	3.9e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—IL6—rheumatoid arthritis	6.65e-07	3.85e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—VEGFA—rheumatoid arthritis	6.49e-07	3.76e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—NOS3—rheumatoid arthritis	6.44e-07	3.73e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—IL6—rheumatoid arthritis	6.41e-07	3.71e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP9—rheumatoid arthritis	6.39e-07	3.71e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NFKB1—rheumatoid arthritis	6.33e-07	3.67e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MAPK8—rheumatoid arthritis	6.22e-07	3.6e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TGFB1—rheumatoid arthritis	6.18e-07	3.58e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL6—rheumatoid arthritis	6.14e-07	3.56e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TP53—rheumatoid arthritis	6.11e-07	3.54e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TP53—rheumatoid arthritis	5.98e-07	3.47e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	5.97e-07	3.46e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TGFB1—rheumatoid arthritis	5.95e-07	3.45e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTGS2—rheumatoid arthritis	5.89e-07	3.41e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TP53—rheumatoid arthritis	5.89e-07	3.41e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—VEGFA—rheumatoid arthritis	5.74e-07	3.33e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—IL6—rheumatoid arthritis	5.67e-07	3.29e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL6—rheumatoid arthritis	5.59e-07	3.24e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6—rheumatoid arthritis	5.47e-07	3.17e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6—rheumatoid arthritis	5.39e-07	3.12e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TGFB1—rheumatoid arthritis	5.27e-07	3.05e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TP53—rheumatoid arthritis	5.09e-07	2.95e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	4.98e-07	2.89e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TP53—rheumatoid arthritis	4.9e-07	2.84e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6—rheumatoid arthritis	4.65e-07	2.7e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6—rheumatoid arthritis	4.49e-07	2.6e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TP53—rheumatoid arthritis	4.34e-07	2.51e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	3.98e-07	2.31e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6—rheumatoid arthritis	3.97e-07	2.3e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	3.63e-07	2.11e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	3.47e-07	2.01e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	3.18e-07	1.84e-06	CbGpPWpGaD
